Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective
- PMID: 12054731
- DOI: 10.1016/S0006-291X(02)00359-5
Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective
Comment in
-
Rebuttal to Deacon and Holst: "Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1" versus "Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective".Biochem Biophys Res Commun. 2002 Aug 16;296(2):229-32. doi: 10.1016/s0006-291x(02)00753-2. Biochem Biophys Res Commun. 2002. PMID: 12163006 No abstract available.
Comment on
-
Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1.Biochem Biophys Res Commun. 2002 Mar 15;291(5):1302-8. doi: 10.1006/bbrc.2002.6607. Biochem Biophys Res Commun. 2002. PMID: 11883961